prindi

Development of safe and effective bacteriophage-mediated therapies against C. difficile infections – a proof-of-concept preclinical study

autor
Rasmussen, Torben Sølbeck
Forster, Sarah
Larsen, Sabina Birgitte
Münchow, Alexandra von
Tranæs, Kaare Dyekæ
Brunse, Anders
Castro Meija, Josue Leonardo
Adamberg, Signe
Hansen, Axel Kornerup
Adamberg, Kaarel
vastutusandmed
Torben Sølbeck Rasmussen, Sarah Forster, Sabina Birgitte Larsen, Alexandra Von Münchow, Kaare Dyekær Tranæs, Anders Brunse, Josue Leonardo Castro Mejia, Signe Adamberg, Axel Kornerup Hansen, Kaarel Adamberg, Camilla Hartmann Friis Hansen, Dennis Sandris Nielsen
allikas
bioRxiv
kirjastus/väljaandja
Cold Spring Harbor
ilmumisaasta
2023
leheküljed
28 p. : ill
leitav
https://doi.org/10.1101/2023.03.17.532897
https://www.biorxiv.org/content/biorxiv/early/2023/03/17/2023.03.17.532897.full.pdf
märksõna
bakteriofaagid
nakkused
ISSN
2692-8205
Open Access
Open Access (roheline)
klassifikaator
6.7
TTÜ struktuuriüksus
keemia ja biotehnoloogia instituut
keel
inglise
Rasmussen, T.S., Forster S., Larsen, S.B., Münchow A. von, Tranæs, K.D., Brunse, A.,Castro Mejia, J.L., Adamberg, S., Hansen, A.K., Adamberg, K. et al Development of safe and effective bacteriophage-mediated therapies against C. difficile infections – a proof-of-concept preclinical study // bioRxiv (2023), 28 p. : ill. https://doi.org/10.1101/2023.03.17.532897 https://www.biorxiv.org/content/biorxiv/early/2023/03/17/2023.03.17.532897.full.pdf